1. Home
  2. CRTO vs EVO Comparison

CRTO vs EVO Comparison

Compare CRTO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRTO
  • EVO
  • Stock Information
  • Founded
  • CRTO 2005
  • EVO 1993
  • Country
  • CRTO France
  • EVO Germany
  • Employees
  • CRTO N/A
  • EVO N/A
  • Industry
  • CRTO Advertising
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRTO Consumer Discretionary
  • EVO Health Care
  • Exchange
  • CRTO Nasdaq
  • EVO Nasdaq
  • Market Cap
  • CRTO 1.4B
  • EVO 1.5B
  • IPO Year
  • CRTO 2013
  • EVO 2021
  • Fundamental
  • Price
  • CRTO $23.88
  • EVO $4.07
  • Analyst Decision
  • CRTO Buy
  • EVO Buy
  • Analyst Count
  • CRTO 11
  • EVO 2
  • Target Price
  • CRTO $44.70
  • EVO $5.90
  • AVG Volume (30 Days)
  • CRTO 396.8K
  • EVO 112.1K
  • Earning Date
  • CRTO 07-31-2025
  • EVO 08-13-2025
  • Dividend Yield
  • CRTO N/A
  • EVO N/A
  • EPS Growth
  • CRTO 107.32
  • EVO N/A
  • EPS
  • CRTO 2.44
  • EVO N/A
  • Revenue
  • CRTO $1,934,668,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • CRTO N/A
  • EVO $10.08
  • Revenue Next Year
  • CRTO $1.96
  • EVO $10.99
  • P/E Ratio
  • CRTO $9.92
  • EVO N/A
  • Revenue Growth
  • CRTO N/A
  • EVO 1.50
  • 52 Week Low
  • CRTO $23.24
  • EVO $2.84
  • 52 Week High
  • CRTO $49.93
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • CRTO 38.43
  • EVO 47.66
  • Support Level
  • CRTO $23.70
  • EVO $4.12
  • Resistance Level
  • CRTO $25.37
  • EVO $4.26
  • Average True Range (ATR)
  • CRTO 0.70
  • EVO 0.11
  • MACD
  • CRTO 0.18
  • EVO -0.01
  • Stochastic Oscillator
  • CRTO 33.33
  • EVO 54.84

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: